GC CELL
GC Cell, founded to specialize in cell therapy, obtained approval for its developed Immunecell-LC as a liver cancer immunotherapy agent in 2007. Immunecell-LC has now finished third-phase clinical trials on liver cancer and brain tumors (glioblastoma/GBM), and is tailed by studies, published in SCI-level journals, on its efficacy in treating liver cancer, brain tumors, and pancreatic cancer (researcher-conducted clinical trial). The company is now researching and developing CAR-T, a next-generation cell immunotherapy agent, and, in partnership with ToolGen, a T-cell-based next-generation cancer immunotherapy agent with greater performance.
GC CELL
Industry:
Biotechnology Life Science Therapeutics
Founded:
2002-01-01
Address:
Yongin, Ch'ungch'ong-namdo, South Korea
Country:
South Korea
Website Url:
http://www.m.globalgreencross.com
Status:
Active
Contact:
+82-31-736-6700
Technology used in webpage:
IPhone / Mobile Compatible Apache Amazon Amazon Route 53 Java EE Apache Tomcat Coyote Amazon South Korea Region
Similar Organizations
Rebirthel
Rebirthel is a biotech company, focused on the Development and operationalization of cell-based cancer immunotherapies.
Stock Details
Official Site Inspections
http://www.m.globalgreencross.com
- Host name: ec2-13-124-105-207.ap-northeast-2.compute.amazonaws.com
- IP address: 13.124.105.207
- Location: Incheon South Korea
- Latitude: 37.4562
- Longitude: 126.7288
- Timezone: Asia/Seoul
- Postal: 21539
More informations about "GC Cell"
Management System | Sustainability | GC Biopharma - GC๋ น์ญ์
According to the policy, GC Company operates both a decision-making organization and a working-level organization to ensure the effective implementation of EHS. Each company's โฆSee details»
Main | GC Biopharma
The new GC Biopharma R&D Center was established in 2013, becoming Korea's largest pharmaceutical R&D facility. The multi-floor complex sprawls over an impressive total floor โฆSee details»
GC Biopharma | GC Biopharma | GC Biopharma - GC๋ น์ญ์
A global health industry leader. GC Biopharma, a biotechnology pioneer in South Korea, is now preparing to take another major leap forward toward ensuring a healthier and happier future โฆSee details»
Green Cross (South Korean company) - Wikipedia
GC Biopharma [Green Cross Corporation] (KRX: 006280) is a biopharmaceutical company headquartered in Yongin, South Korea. GC Biopharma specializes in the development and commercialization of vaccines, protein therapies, and therapeutic antibodies for use in the fields of oncology and infectious disease. See details»
Main | GC Biopharma - GC๋ น์ญ์
Great Company A producer of a varicella vaccine that is popular worldwide A seasonal flu vaccine that is revolutionizing the Korean and international markets An innovative recombinant protein โฆSee details»
Green Cross - Overview, News & Similar companies - ZoomInfo
Dec 17, 2023 Who is Green Cross. GCAM, Inc., headquartered in Fullerton, CA, was established in 2002 and a member of South Korea's GC group of companies. GCAM runs โฆSee details»
Global Green
He asked that we use our passion and our voices to preserve the beauty and opportunities we have been given, and as an organization we will continue to respect his legacy. He will be greatly missed, never forgotten, and honored โฆSee details»
Green Cross Holding - Crunchbase Investor Profile
GC holding company, which operates pharmaceutical, biotechnology, distribution system, life insurance, and healthcare entities.See details»
GC Pharma to Establish Curevo - a Seattle-based New Company
May 21, 2018 For more information, please visit www.globalgreencross.com About IDRI. As a non-profit global health organization, IDRI (Infectious Disease Research Institute) takes a โฆSee details»
Main | GC Biopharma
Main | GC BiopharmaSee details»
GC Pharma | VentureRadar
"GC Pharma (formerly known as Green Cross Corporation) is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines.See details»
MUSEUM | GC Pharma - GC๋ น์ญ์
Adventures and Innovations toward Enhancing the Companyโs Value. 1995~2003. Questioning the prevailing opinion that manufacturing was the only key to growth, GC began to look for โฆSee details»
GC Pharma to Establish Curevo - Curevo Vaccine
May 18, 2018 For more information, please visit www.globalgreencross.com About IDRI As a non-profit global health organization, IDRI (Infectious Disease Research Institute) takes a โฆSee details»
GC Biopharma Company Profile 2024: Stock Performance
Www.globalgreencross.com. Formerly Known As. Sudo Microorganism Medical Supplies, GC Pharma, Sudo Microorganism Medical Supplies Company, Green Cross Company, Green โฆSee details»
GC Cell - Crunchbase Investor Profile & Investments
GC Cell specialize in cell therapy, obtained approval for its developed Immunecell-LC as a liver cancer immunotherapy agent in 2007.See details»
GC 5131A - AdisInsight
GC 5131A is a plasma-derived intravenous immunoglobulin against SARS-CoV-2 virus, being developed by GC Pharma, for the treatment of COVID-2019 infections. TheSee details»
NEWS | Corporate Relations | GC Pharma - GC๋ น์ญ์
GC Biopharma Announces US FDA Approval for ALYGLOโข (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)See details»
10-Year Commitment to Global Health and Rights: - Affaires โฆ
4 days ago I. Introduction Context. In June 2019, Prime Minister Trudeau announced that Canada would increase its global health funding between 2020 and 2030 to reach an average โฆSee details»
Global Projects | research | GC Biopharma - GC๋ น์ญ์
Hunterase - Hunter Syndrome Treatment. Hunterase, first approved in Korea in 2012, is the second Hunter syndrome treatment developed globally. Since its launch in the Korean market, โฆSee details»
GC 5113A - AdisInsight
If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโs network Login with username/password or try to โฆSee details»